C F Heyns1, D C Marais. 1. Department of Urology, University of Stellenbosch and Tygerberg Hospital, Western Cape, South Africa.
Abstract
PURPOSE: We prospectively evaluated the American Urological Association (AUA) symptom index and maximum urine flow for predicting urethral stricture recurrence in men with a previous diagnosis of urethral stricture disease. MATERIALS AND METHODS: Patients were recruited at our urethral stricture clinic, where all newly diagnosed and previously treated men with urethral stricture present and are treated. The AUA symptom index was completed and uroflowmetry was done. The stricture was calibrated using Jacques catheters. If an 18Fr catheter could not be passed, a retrograde urethrogram was performed. Patients were treated with filiform dilation or direct vision internal urethrotomy. Uroflowmetry was repeated when the catheter was removed 3 days later and the AUA symptom index was repeated 1 month later. RESULTS: Data on 49 patients (170 consultations) between March 2000 and August 2001 were analyzed. Average patient age was 48 years. There was a significant negative correlation of urethral diameter with AUA symptom index and of AUA symptom index with maximum urine flow as well as a significant positive correlation of urethral diameter with maximum urine flow. We evaluated the usefulness of AUA symptom index and maximum urine flow at different cutoff levels for predicting urethral stricture in our study group. Using an AUA symptom index of greater than 10 or maximum urine flow of less than 15 ml. per second as cutoff values provided 93% sensitivity, 68% specificity, 78% positive predictive value, 89% negative predictive value and 82% overall accuracy. This method could have prevented further invasive studies in 34% of patients, while a clinically significant stricture would have been missed in only 4.3%. CONCLUSIONS: AUA symptom index combined with maximum urine flow is an accurate, time-saving and cost-effective tool for predicting recurrent stricture in patients with a known urethral stricture. It can be used to direct decision making on further invasive studies and treatment.
PURPOSE: We prospectively evaluated the American Urological Association (AUA) symptom index and maximum urine flow for predicting urethral stricture recurrence in men with a previous diagnosis of urethral stricture disease. MATERIALS AND METHODS:Patients were recruited at our urethral stricture clinic, where all newly diagnosed and previously treated men with urethral stricture present and are treated. The AUA symptom index was completed and uroflowmetry was done. The stricture was calibrated using Jacques catheters. If an 18Fr catheter could not be passed, a retrograde urethrogram was performed. Patients were treated with filiform dilation or direct vision internal urethrotomy. Uroflowmetry was repeated when the catheter was removed 3 days later and the AUA symptom index was repeated 1 month later. RESULTS: Data on 49 patients (170 consultations) between March 2000 and August 2001 were analyzed. Average patient age was 48 years. There was a significant negative correlation of urethral diameter with AUA symptom index and of AUA symptom index with maximum urine flow as well as a significant positive correlation of urethral diameter with maximum urine flow. We evaluated the usefulness of AUA symptom index and maximum urine flow at different cutoff levels for predicting urethral stricture in our study group. Using an AUA symptom index of greater than 10 or maximum urine flow of less than 15 ml. per second as cutoff values provided 93% sensitivity, 68% specificity, 78% positive predictive value, 89% negative predictive value and 82% overall accuracy. This method could have prevented further invasive studies in 34% of patients, while a clinically significant stricture would have been missed in only 4.3%. CONCLUSIONS: AUA symptom index combined with maximum urine flow is an accurate, time-saving and cost-effective tool for predicting recurrent stricture in patients with a known urethral stricture. It can be used to direct decision making on further invasive studies and treatment.
Authors: Christopher A Tam; Sean P Elliott; Bryan B Voelzke; Jeremy B Myers; Alex J Vanni; Benjamin N Breyer; Thomas G Smith; Christopher D McClung; Bradley A Erickson Journal: Urology Date: 2016-04-21 Impact factor: 2.649
Authors: Javier Tinaut-Ranera; Miguel Ángel Arrabal-Polo; Sergio Merino-Salas; Mercedes Nogueras-Ocaña; Víctor Manuel López-León; Francisco Palao-Yago; Miguel Arrabal-Martín; Clara Lahoz-García; Miguel Alaminos; Armando Zuluaga-Gomez Journal: Can Urol Assoc J Date: 2014 Jan-Feb Impact factor: 1.862
Authors: Christopher A Tam; Bryan B Voelzke; Sean P Elliott; Jeremy B Myers; Christopher D McClung; Alex J Vanni; Benjamin N Breyer; Bradley A Erickson Journal: Urology Date: 2016-02-10 Impact factor: 2.649
Authors: Benjamin N Breyer; Jack W McAninch; Jared M Whitson; Michael L Eisenberg; Viraj A Master; Bryan B Voelzke; Sean P Elliott Journal: Urology Date: 2009-04-15 Impact factor: 2.649
Authors: Nima Baradaran; Lindsay A Hampson; Todd C Edwards; Bryan B Voelzke; Benjamin N Breyer Journal: Curr Urol Rep Date: 2018-05-17 Impact factor: 3.092